COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,556 Articles (22,881 medRxiv, 8,675 bioRxiv)

Most recent first Previous |  Page 803: Articles 8021-8030  | Next

Safety of the BNT162b2 mRNA COVID-19 Vaccine in Children below 5 Years in Germany (CoVacU5): An Investigator-initiated Retrospective Cohort Study
Toepfner, N., von Meissner, W. C. G., Strumann, C., Drinka, D., Stuppe, D., Jorczyk, M., Moor, J., Pueschel, J., Liss, M., von Poblotzki, E., Berner, R., Moor, M. B., Chao, C.-M.
10.1101/2022.05.17.22275005 — Posted: 2022-05-23
COVID-19 symptoms and duration of direct antigen test positivity at a community testing and surveillance site, January 2021-2022
Marquez, C., Kerkhoff, A., Schrom, J., Rojas, S., Black, D., Mitchell, A., Wang, C.-Y., Pilarowski, G., Ribeiro, S., Jones, D., Payan, J., Manganelli, S., Rojas, S., Lemus, J., Jain, V., Chamie, G., Tulier-Laiwa, V., Petersen, M., DeRisi, J., Havlir, D.
10.1101/2022.05.19.22274968 — Posted: 2022-05-23
A Mesoscale Agent Based Modeling Framework For Flow-mediated Infection Transmission In Indoor Occupied Spaces
Mukherjee, D., Wadhwa, G.
10.1101/2022.05.20.22275409 — Posted: 2022-05-23
Low testing rates limit the ability of genomic surveillance programs to monitor SARS-CoV-2 variants: a mathematical modelling study
Han, A. X., Toporowski, A., Sacks, J. A., Perkins, M., Briand, S., van Kerkhove, M., Hannay, E., Carmona, S., Rodriguez, B., Parker, E., Nichols, B. E., Russell, C. A.
10.1101/2022.05.20.22275319 — Posted: 2022-05-23
Machine Learning for Identifying Data-Driven Subphenotypes of Incident Post-Acute SARS-CoV-2 Infection Conditions with Large Scale Electronic Health Records: Findings from the RECOVER Initiative
Zhang, H., ZANG, C., Xu, Z., Zhang, Y., Xu, J., Bian, J., Morozyuk, D., Khullar, D., Zhang, Y., Nordvig, A. S., Schenck, E. J., Shenkman, E. A., Rothman, R. L., Block, J. P., Lyman, K., Weiner, M., Carton, T. W., Wang, F., Kaushal, R.
10.1101/2022.05.21.22275412 — Posted: 2022-05-23
Omicron and vaccines: An analysis on the decline in COVID-19 mortality
Larrauri, B., Malbran, A., Larrauri, J. A.
10.1101/2022.05.20.22275396 — Posted: 2022-05-23
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe COVID-19 outcomes in non-hospitalised patients: an observational cohort study using the OpenSAFELY platform
Zheng, B., Green, A. C., Tazare, J., Curtis, H. J., Fisher, L., Nab, L., Schultze, A., Mahalingasivam, V., Parker, E., Hulme, W. J., Bacon, S. C., DeVito, N. J., Bates, C., Evans, D., Inglesby, P., Drysdale, H., Davy, S., Cockburn, J., Morton, C. E., Hickman, G., Ward, T., Smith, R. M., Parry, J., Hester, F., Harper, S., Mehrkar, A., Eggo, R. M., Walker, A. J., Evans, S. J., Douglas, I. J., MacKenna, B., Goldacre, B., Tomlinson, L. A.
10.1101/2022.05.22.22275417 — Posted: 2022-05-23
Social divisions and risk perception can drive divergent epidemic dynamics and large second and third waves
Harris, M. J., Mordecai, E. A.
10.1101/2022.05.20.22275407 — Posted: 2022-05-23
Assessment of subtle cognitive impairments in patients with post-COVID syndrome with the tablet-based Oxford Cognitive Screen-Plus (OCS-Plus).
Kozik, V., Reuken, P., Utech, I., Gramlich, J., Stallmach, Z., Demeyere, N., Stallmach, A., Finke, K.
10.1101/2022.05.23.22275442 — Posted: 2022-05-23
Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors
Cheetham, N. J., Kibble, M., Wong, A., Silverwood, R. J., Knuppel, A., Williams, D. M., Hamilton, O. K. L., Lee, P. H., Bridger Staatz, C., Di Gessa, G., Zhu, J., Katikireddi, S. V., Ploubidis, G. B., Thompson, E. J., Bowyer, R. C. E., Zhang, X., Abbasian, G., Garcia, M. P., Hart, D., Seow, J., Graham, C., Kouphou, N., Acors, S., Malim, M. H., Mitchell, R. E., Northstone, K., Major-Smith, D., Matthews, S., Breeze, T., Crawford, M., Molloy, L., Kwong, A. S. F., Doores, K. J., Chaturvedi, N., Duncan, E. L., Timpson, N. J., Steves, C. J.
10.1101/2022.05.19.22275214 — Posted: 2022-05-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).